NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10

Abstract Prostate cancer (PCa) is one of the most common male genitourinary system malignancies. Despite the significant benefits of anti-PD-L1 immune checkpoint inhibitor therapy in other cancers, the reasons for its poor therapeutic efficacy in prostate cancer (PCa) remain unclear.NDR1 plays an im...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Meiling Fu, Jinxin Li, Zuodong Xuan, Zeyuan Zheng, Yankuo Liu, Zeyi Zhang, Jianzhong Zheng, Min Zhong, Bin Liu, Yifan Du, Lei Zhang, Huimin Sun
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	BMC 2024-09-01
श्रृंखला:	Cell Communication and Signaling
विषय:	Prostate cancer NDR1/STK38, PD-L1 Immune escape Immune checkpoint Blockade Anti-PD-1 therapy
ऑनलाइन पहुंच:	https://doi.org/10.1186/s12964-024-01805-5
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!